NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 204-208

  Schultz Thater, E ^a   Noppen, C ^a   Gudat, F ^b   Durmuller U ^b   Zajac, P ^a   Kocher, T ^a   Heberer, M ^a   Spagnoli, G C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cancer testis antigens; Immunodetection; Immunotherapy; Tumour associated antigens

Indexed keywords

CYTOPLASM PROTEIN; GENE PRODUCT; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; CANCER IMMUNOTHERAPY; CELL LINE; CELLULAR DISTRIBUTION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; TUMOR CELL;

EID: 0034046918     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1251     Document Type: Article

References (23)

1. Boon T and van der Bruggen P (1996) Human tumor antigens recognised by T lymphocytes. J Exp Med 183: 725-729
2. Carrel S, Schreyer M, Spagnoli G, Cerottini J-C and Rimoldi D (1996) Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. Int J Cancer 67: 417-422
3. Chaux P, Vantomme V, Stroobant V, Thielemans K, Corthals J, Luiten R, Eggermont AM, Boon T and van der Bruggen P (1999) Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J Exp Med 189: 767-778
4. Chen Y-T, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, van der Bruggen P, Boon T and Old LJ (1994) Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 91: 1004-1008
5. Chen Y-T, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918
6. Chen Y-T, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A and Old LJ (1998) Identification of multiple cancer/testis antigens by allogenic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919-6923
7. Gudat F, Zuber M, Dürmüller U, Kocher T, Schaefer C, Noppen C and Spagnoli GC (1996) The tumour-associated antigen MAGE-1 is detectable in formalin-fixed paraffin section of malignant melanoma. Virchows Arch 429: 77-81
8. Hofbauer GFL, Schaefer C, Noppen C, Böni R, Kamarashev J, Nestle FO, Spagnoli GC and Dummer R (1997) MAGE-3 immunoreactivity in formalin-fixed, paraffin embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol 151: 1549-1553
9. Jäger E, Chen Y-T, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ and Knuth A (1998) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human Histocompalibility Leukocyte Antigen (HLA)-A2-binding epitopes. J Exp Med 187: 265-270
10. Jurk M, Kremmer E, Schwarz U, Forster R and Winnacker EL (1998) MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int J Cancer 75: 762-766
11. Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M and Spagnoli GC (1995) Identilication and intracellular location of MAGE-3 gene product. Cancer Res 55: 2236-2239
12. Lethé B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E and Boon T (1998) LAGE-1, a new gene with tumor specificity. Int J Cancer 76: 903-908
13. Manici S, Sturniolo T, Imro MA, Hammer J, Sinigaglia F, Noppen C, Spagnoli G, Mazzi B, Bellone M, Dellabona P and Protti MP (1999) Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med 189: 871-876
14. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y, Canon J-L, Laurent C, Naeyaert J-M, Plagne R, Deramaeker R, Knuth A, Juger E, Brasseur F, Herman J, Coulie PG and Boon T (1995) Tumor-regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 63: 883-885
15. Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier M-H, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Liénard D, Beauduin M, Dietrich P-Y, Russo V, Kerger J, Masucci G, Jäger E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, van der Bruggen P and Boon T (1999) Tumor regressions observed in patients with metastatic melanoma treated by an antigenic peptide encoded by gene MAGE-3 and presented by HLA-AI. Int J Cancer 80: 219-230
16. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G and Schadendorf D (1999) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 4: 328-332
17. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813
18. Schultz-Thater E, Juretic A, Dellabona P, Lüscher U, Siegrist W, Harder F, Heberer M, Zuber M and Spagnoli GC (1994) MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 59: 435-439
19. Stockert E, Jäger E, Chen Y-T, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A and Old LJ (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187: 1349-1354
20. Thurner B, Haendle I, Röder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Bröcker EB, Steinman RM, Enk A, Kämpgen E and Schuler G (1999) Vaccination with Mage-3A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190: 1669-1678
21. Türeci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG and Pfreundschuh M (1998) The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56: 4766-4772
22. Van Baren N, Brasseur F, Godelaine D, Hames G, Ferrant A, Lehmann F, André M, Ravoet C, Doyen C, Spagnoli GC, Bakkus M, Thielemans K and Boon T (1999) Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 94: 1156-1164
23. Wang RF, Johnston SL, Zeng G, Topalian SL, Schwartzentruber DJ and Rosenberg SA (1998) A breast and melanoma-shared tumor antigen T cell responses to antigenic peptides translated from different open reading frames. J Immunol 161: 3598-3606